Provide feedbackProvide feedback
Home :: Endocrinology

Heart failure rates at young ages higher in black versus white patients, researchers find

Friday, April 10 2009 | Comments
Evidence Grade 2 What's This?

Black patients are more likely than white patients to experience heart failure (HF) before age 50 years, especially if they have hypertension, obesity, or systolic dysfunction as young adults, the CARDIA study indicates. For 20 years, the incidence and predictors of HF were prospectively evaluated in 5,115 black and white people (age range at baseline, 18-30 years).  Researchers performed examinations and interviews at regular intervals and evaluated patient medical records to confirm...

Black patients are more likely than white patients to experience heart failure (HF) before age 50 years, especially if they have hypertension, obesity, or systolic dysfunction as young adults, the CARDIA study indicates.

For 20 years, the incidence and predictors of HF were prospectively evaluated in 5,115 black and white people (age range at baseline, 18-30 years).  Researchers performed examinations and interviews at regular intervals and evaluated patient medical records to confirm information as needed. They also determined clinical and echocardiographic antecedents.

Throughout follow-up, 27 patients developed incident HF, leading to 5 deaths in black patients and 0 in white subjects. Significantly more black patients than white ones developed HF (26 vs 1, respectively; P=.001).

The cumulative incidence of HF ranged from 1.1% in black women and 0.9% in black men (mean age of onset, 39 years) to 0.08% in white women and 0% in white men.

Multivariate analyses indicated that in black subjects aged 18 to 30 years, diastolic blood pressure (BP; per 10 mm Hg increase: hazard ratio [HR], 2.1), body mass index (per 5.7 units increase: HR, 1.4), HDL cholesterol (per 13.3 mg/dL increase: HR, 0.6), and chronic kidney disease (HR, 19.8) were independent predictors of HF 15 years later, on average.

For example, three quarters of patients who had HF later on experienced hypertension by age 40 years.

When examining antecedents more proximal to HF onset, higher systolic and diastolic BP and diabetes presence were independently linked to HF risk. Finally, depressed systolic function on echocardiogram when the patients were aged 23 to 35 years was independently associated with HF developing 10 years later, on average.

The researchers summarized that during the study period, the incidence of HF in black participants before age 50 years was 20 times that of white subjects. They suggested that just 21 young black patients with hypertension would need to be treated to prevent 1 HF before age 50 years.

The study authors concluded that the antecedents identified in this study "could become targets for screening and interventions aimed at the prevention of HF." (Bibbins-Domingo K, et al. N Engl J Med 2009;360:1179-90.)

Latest News

Community-based diabetes prevention program appears to reduce CHD risk in overweight adults with prediabetes Verusmed

Wednesday, March 25 2009 | Comments
Evidence Grade 3 What's This?
Community-based delivery of a diabetes prevention program is associated with significant reductions in 10-year coronary heart disease (CHD) risk for overweight adults with prediabetes, according to findings from the DEPLOY study.

In the trial, researchers randomized YMCA facilities to receive training and support for delivering a formal, group-based adaptation of the Diabetes Prevention Program lifestyle intervention or a control condition in which facilities provided...

Metabolic syndrome associated with increased risk of developing cognitive impairment, results indicate Verusmed

Monday, March 23 2009 | Comments
Evidence Grade 2 What's This?
Older women with the metabolic syndrome are more likely to develop cognitive impairment relative to their counterparts without the metabolic syndrome, according to findings from a prospective study conducted in 25 countries.

The authors of the study noted that the evidence linking the metabolic syndrome with cognitive impairment is growing, but there are some conflicting results. To further evaluate this association, they assessed the 4-year risk of cognitive impairment in...
Tags: Alzheimer's Disease & Dementia


Lowering BP reduces risk of renal events in patients with type 2 diabetes, regardless of baseline BP, findings show Verusmed

Tuesday, March 17 2009 | Comments
Evidence Grade 1 What's This?
Reducing blood pressure (BP) with the combination of an angiotensin-converting enzyme inhibitor and a diuretic seems to reduce the risk of renal events in patients with type 2 diabetes, even in patients with BP levels below currently recommended targets, according to an analysis of renal outcomes in the ADVANCE trial.

During the ADVANCE trial, 11,140 individuals aged >=55 years with type 2 diabetes were randomized to receive perindopril plus indapamide (2 mg/0.625 mg for the...

Drugs that lower BP reduce cardiovascular morbidity, mortality in patients undergoing dialysis, meta-analysis finds Verusmed

Tuesday, March 17 2009 | Comments
Evidence Grade 1 What's This?
Blood pressure (BP)-lowering agents should be standard therapy for patients who are undergoing dialysis, a group of Australian and Dutch researchers suggest.

Since there has been uncertainty about the usefulness and tolerability of reducing BP in this patient population, the investigators conducted a systematic review and meta-analysis to clarify the issue. They found 8 randomized controlled trials from 1950 to November 2008 that evaluated BP-lowering agents and recorded...